Approved Symbol |
Approved Name |
Location |
Source |
RPS6KA4 |
ribosomal protein S6 kinase, 90kDa, polypeptide 4 |
11q11-q13 |
Mapped by significant region |
PRKCB |
protein kinase C, beta |
16p12 |
Mapped by significant region |
PLA2G2A |
phospholipase A2, group IIA (platelets, synovial fluid) |
1p35 |
Mapped by PBA pathway |
PLA2G1B |
phospholipase A2, group IB (pancreas) |
12q23-qter |
Mapped by PBA pathway |
FGF4 |
fibroblast growth factor 4 |
11q13.3 |
Mapped by significant region |
PLA2G2E |
phospholipase A2, group IIE |
1p36.13 |
Mapped by PBA pathway |
FGF9 |
fibroblast growth factor 9 (glia-activating factor) |
13q11-q12 |
Mapped by significant region |
PLA2G2D |
phospholipase A2, group IID |
1p36.12 |
Mapped by PBA pathway |
PLA2G4B |
phospholipase A2, group IVB (cytosolic) |
15q11.2-q21.3 |
Mapped by PBA pathway |
PLA2G3 |
phospholipase A2, group III |
22q12.2 |
Mapped by PBA pathway |
PLA2G5 |
phospholipase A2, group V |
1p36-p34 |
Mapped by PBA pathway |
CACNA1I |
calcium channel, voltage-dependent, T type, alpha 1I subunit |
22q13.1 |
Mapped by CNV |
PLA2G6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
22q13.1 |
Mapped by PBA pathway |
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
6q22.33 |
Mapped by LD-proxy; Mapped by significant region |
MAPK1 |
mitogen-activated protein kinase 1 |
22q11.2 |
Mapped by LD-proxy |
DAXX |
death-domain associated protein |
6p21.3 |
Mapped by LD-proxy; Mapped by PBA pathway |
MAPT |
microtubule-associated protein tau |
17q21 |
Mapped by LD-proxy; Mapped by PBA pathway |
CACNA1F |
calcium channel, voltage-dependent, L type, alpha 1F subunit |
Xp11.23 |
Mapped by LD-proxy; Mapped by PBA pathway; Mapped by literature SNP |
PPP3R2 |
protein phosphatase 3, regulatory subunit B, beta |
9q31 |
Mapped by significant region |
MAPK9 |
mitogen-activated protein kinase 9 |
5q35 |
Mapped by CNV |
RASA1 |
RAS p21 protein activator (GTPase activating protein) 1 |
5q13 |
Mapped by PBA pathway |
MAPK3 |
mitogen-activated protein kinase 3 |
16p11.2 |
Mapped by CNV |
FGF3 |
fibroblast growth factor 3 |
11q13 |
Mapped by significant region |
CDC25B |
cell division cycle 25 homolog B (S. pombe) |
20p13 |
Mapped by CNV |
FGF19 |
fibroblast growth factor 19 |
11q13.1 |
Mapped by significant region |
DUSP2 |
dual specificity phosphatase 2 |
2q11 |
Mapped by LD-proxy |
TAOK2 |
TAO kinase 2 |
16p11.2 |
Mapped by CNV |
CACNG5 |
calcium channel, voltage-dependent, gamma subunit 5 |
17q24 |
Mapped by PBA pathway |
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
11q13 |
Mapped by significant region |
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
14q11.2 |
Mapped by significant region |
CACNB4 |
calcium channel, voltage-dependent, beta 4 subunit |
2q22-q23 |
Mapped by PBA pathway |
CACNG1 |
calcium channel, voltage-dependent, gamma subunit 1 |
17q24 |
Mapped by PBA pathway |
CACNG2 |
calcium channel, voltage-dependent, gamma subunit 2 |
22q13.1 |
Mapped by PBA pathway |
STMN1 |
stathmin 1 |
1p36.11 |
Mapped by PBA pathway |
CACNG4 |
calcium channel, voltage-dependent, gamma subunit 4 |
17q24 |
Mapped by PBA pathway |
MAP3K11 |
mitogen-activated protein kinase kinase kinase 11 |
11q13.1-q13.3 |
Mapped by significant region |
MAP4K2 |
mitogen-activated protein kinase kinase kinase kinase 2 |
11q13.1 |
Mapped by significant region |
MAPK7 |
mitogen-activated protein kinase 7 |
17p11.2 |
Mapped by significant region |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
11q13 |
Mapped by significant region |
CACNA1B |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
9q34 |
Mapped by PBA pathway |
HSPA8 |
heat shock 70kDa protein 8 |
11q24.1 |
Mapped by significant region |
CACNA1A |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
19p13 |
Mapped by PBA pathway |
CACNB1 |
calcium channel, voltage-dependent, beta 1 subunit |
17q21-q22 |
Mapped by PBA pathway |
CACNA2D1 |
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
7q21-q22 |
Mapped by PBA pathway |
CACNB3 |
calcium channel, voltage-dependent, beta 3 subunit |
12q13 |
Mapped by PBA pathway |
CACNB2 |
calcium channel, voltage-dependent, beta 2 subunit |
10p12 |
Mapped by PBA pathway |
CACNA1G |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
17q22 |
Mapped by PBA pathway |
CRKL |
v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
22q11.21 |
Mapped by CNV |
CACNA1D |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
3p14.3 |
Mapped by PBA pathway |
CACNA1S |
calcium channel, voltage-dependent, L type, alpha 1S subunit |
1q32 |
Mapped by PBA pathway |
CACNA1H |
calcium channel, voltage-dependent, T type, alpha 1H subunit |
16p13.3 |
Mapped by PBA pathway |
TGFBR1 |
transforming growth factor, beta receptor 1 |
9q22 |
Mapped by significant region |
CACNA1E |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
1q25-q31 |
Mapped by PBA pathway; Mapped by significant region |
PAK1 |
p21 protein (Cdc42/Rac)-activated kinase 1 |
11q13-q14 |
Mapped by significant region |
PLA2G10 |
phospholipase A2, group X |
16p13.1-p12 |
Mapped by PBA pathway; Mapped by significant region |
DUSP14 |
dual specificity phosphatase 14 |
17q12 |
Mapped by CNV |
HSPA6 |
heat shock 70kDa protein 6 (HSP70B') |
1q23.3 |
Mapped by CNV |
GADD45G |
growth arrest and DNA-damage-inducible, gamma |
9q22.1-q22.2 |
Mapped by significant region |